<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2079-5696</issn><issn publication-format="electronic">2079-5831</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">34108</article-id><article-id pub-id-type="doi">10.26442/20795696.2020.5.200416</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLE</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Features of the ovarian reserve of women of reproductive age suffering from autoimmune diseases</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности овариального резерва женщин репродуктивного возраста, страдающих аутоиммунными заболеваниями</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8425-0020</contrib-id><name-alternatives><name xml:lang="en"><surname>Andreeva</surname><given-names>Elena N.</given-names></name><name xml:lang="ru"><surname>Андреева</surname><given-names>Елена Николаевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Endocrinology Research Centre, Yevdokimov Moscow State University of Medicine and Dentistry</p></bio><bio xml:lang="ru"><p>д-р мед. наук, ФГБУ «НМИЦ эндокринологии», ФГБОУ ВО «МГМСУ им. А.И. Евдокимова»</p></bio><email>endogin@mail.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4979-7420</contrib-id><name-alternatives><name xml:lang="en"><surname>Grigoryan</surname><given-names>Olga R.</given-names></name><name xml:lang="ru"><surname>Григорян</surname><given-names>Ольга Рафаэльевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.), Endocrinology Research Centre</p></bio><bio xml:lang="ru"><p>д-р мед. наук, ФГБУ «НМИЦ эндокринологии»</p></bio><email>iceberg1995@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0696-5367</contrib-id><name-alternatives><name xml:lang="en"><surname>Absatarova</surname><given-names>Yulia S.</given-names></name><name xml:lang="ru"><surname>Абсатарова</surname><given-names>Юлия Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci (Med.), Endocrinology Research Centre</p></bio><bio xml:lang="ru"><p>канд. мед. наук, ФГБУ «НМИЦ эндокринологии»</p></bio><email>korsil2008@yandex.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3222-5936</contrib-id><name-alternatives><name xml:lang="en"><surname>Yarovaya</surname><given-names>Irina S.</given-names></name><name xml:lang="ru"><surname>Яровая</surname><given-names>Ирина Сергеевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci (Med.), Endocrinology Research Centre</p></bio><bio xml:lang="ru"><p>канд. мед. наук, ФГБУ «НМИЦ эндокринологии»</p></bio><email>yarovaya.is@yandex.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5826-3186</contrib-id><name-alternatives><name xml:lang="en"><surname>Mikheev</surname><given-names>Robert K.</given-names></name><name xml:lang="ru"><surname>Михеев</surname><given-names>Роберт Константинович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Student, Endocrinology Research Centre, Yevdokimov Moscow State University of Medicine and Dentistry</p></bio><bio xml:lang="ru"><p>студент лечебного фак-та, ФГБУ «НМИЦ эндокринологии», ФГБОУ ВО «МГМСУ им. А.И. Евдокимова»</p></bio><email>mikheev-robert@list.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Endocrinology Research Centre</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр эндокринологии» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Yevdokimov Moscow State University of Medicine and Dentistry</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Endocrinology Research Centre, Moscow</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр эндокринологии» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-11-23" publication-format="electronic"><day>23</day><month>11</month><year>2020</year></pub-date><volume>22</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>27</fpage><lpage>30</lpage><history><date date-type="received" iso-8601-date="2020-05-24"><day>24</day><month>05</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://gynecology.orscience.ru/2079-5831/article/view/34108">https://gynecology.orscience.ru/2079-5831/article/view/34108</self-uri><abstract xml:lang="en"><p>The reproductive potential of a woman depends on indicators of the ovarian reserve, such as the anti-Muller hormone (AMH) and the number of antral follicles (NAF). Autoimmune diseases have a significant effect on fertility and contribute to the development of premature ovarian failure.</p> <p><bold>Aim. </bold>To evaluate the parameters of the ovarian reserve in patients with type 1 diabetes mellitus, carriers of antibodies to the thyroid gland in a state of euthyroidism and compare them with similar parameters in healthy women.</p> <p><bold>Materials and methods. </bold>In the first block of the study, the level of AMH, follicle-stimulating hormone, luteinizing hormone, NAF was studied among 224 women with diabetes and 230 healthy women in the control group. In block II, the level of the above hormonal indices was studied in 35 carriers of antithyroid antibodies in the state of euthyroidism and 35 healthy women.</p> <p><bold>Results. </bold>In patients with type 1 diabetes, the level of AMH, NAF was statistically significantly lower when compared with the control group. Among carriers of antithyroid antibodies and healthy women, no difference in AMH and NAF was found.</p> <p><bold>Conclusion.</bold> The autoimmune processes accompanying diabetes are more influenced by the ovarian reserve indices than autoimmune aggression to the tissues of the thyroid gland.</p></abstract><trans-abstract xml:lang="ru"><p>Репродуктивный потенциал женщины зависит от показателей овариального резерва, таких как антимюллеров гормон (АМГ) и количество антральных фолликулов (КАФ). Аутоиммунные заболевания оказывают значимое влияние на фертильность и способствуют развитию преждевременной недостаточности яичников.</p> <p><bold>Цель.</bold><bold> </bold>Оценить показатели овариального резерва у пациенток с сахарным диабетом 1-го типа, носительниц антител к щитовидной железе в состоянии эутиреоза и сравнить их с аналогичными параметрами у здоровых женщин.</p> <p><bold>Материалы и методы.</bold><bold> </bold>В I блоке исследования провели изучение уровня АМГ, фолликулостимулирующего гормона, лютеинизирующего гормона, КАФ среди 224 женщин с сахарным диабетом и 230 здоровых женщин группы контроля. Во II блоке исследован уровень вышеуказанных гормональных показателей у 35 носительниц антитиреоидных антител в состоянии эутиреоза и 35 здоровых женщин.</p> <p><bold>Результаты.</bold><bold> </bold>У больных сахарным диабетом 1-го типа уровень АМГ, КАФ оказался статистически значимо меньше при сравнении с группой контроля. Среди носительниц антитиреоидных антител и здоровых женщин разницы в показателях АМГ и КАФ не обнаружили.</p> <p><bold>Заключение.</bold> На показатели овариального резерва в большей мере влияют аутоиммунные процессы, сопровождающие сахарный диабет, чем аутоиммуноагрессия к тканям щитовидной железы.</p></trans-abstract><kwd-group xml:lang="en"><kwd>type 1 diabetes mellitus</kwd><kwd>thyroid antibodies</kwd><kwd>premature ovarian failure</kwd><kwd>anti-mullerian hormone</kwd><kwd>antral follicles</kwd><kwd>ovarian reserve</kwd><kwd>autoimmune diseases</kwd><kwd>autoimmune thyroiditis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>сахарный диабет 1-го типа</kwd><kwd>антитела к щитовидной железе</kwd><kwd>преждевременная недостаточность яичников</kwd><kwd>антимюллеров гормон</kwd><kwd>антральные фолликулы</kwd><kwd>овариальный резерв</kwd><kwd>аутоиммунные заболевания</kwd><kwd>аутоиммунный тиреоидит</kwd></kwd-group><funding-group><funding-statement xml:lang="en">Russian Science Foundation “Autoimmune endocrinopathies with multiple organ lesions: genomic, post-genomic and metabolic markers. Genetic risk prediction, monitoring, early predictors, personalized correction and rehabilitation "(RSF grant No. 17-75-30035)</funding-statement><funding-statement xml:lang="ru">Российский научный фонд «Аутоиммунные эндокринопатии с полиорганными поражениями: геномные, постгеномные и метаболомные маркеры. Генетическое прогнозирование рисков, мониторинг, ранние предикторы, персонализированная коррекция и реабилитация» (грант РНФ № 17-75-30035)</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Dewailly D, Andersen CY, Balen A et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update 2014; 20 (3): 370–85. DOI: 10.1093/humupd/dmt062</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Desai MK, Brinton RD. Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan. Front Endocrinol (Lausanne) 2019; 10: 265. DOI: 10.3389/fendo.2019.00265</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Sjoberg L, Pitkaniemi J, Harjutsalo V et al. Menopause in women with type 1 diabetes. Menopause 2011; 18: 158–63. DOI: 10.1097/gme.0b013e3181ef3af0</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Li L, Jing Y, Dong MZ et al. Type 1 diabetes affects zona pellucida and genome methylation in oocytes and granulosa cells. Mol Cell Endocrinol 2020; 500: 110627. DOI: 10.1016/j.mce.2019.110627</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010; 31 (5): 702–55. DOI: 10.1210/er.2009-0041</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Kuroda K, Uchida T, Nagai S. Elevated serum thyroid-stimulating hormone is associated with decreased anti-Müllerian hormone in infertile women of reproductive age. J Assist Reprod Genet 2015; 32 (2): 243–7. DOI: 10.1007/s10815-014-0397-7</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Practice Committee of the American Society for Reproductive Medicine. Subclinical hypothyroidism in the infertile female population: a guideline. Fertil Steril 2015; 104 (3): 545–53. DOI: 10.1016/j.fertnstert.2015.05.028</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Kim C, Miller RS, Braffett BH et al. Ovarian markers and irregular menses among women with type 1 diabetes in the Epidemiology of Diabetes Interventions and Complications study. Clin Endocrinol (Oxf) 2018; 88 (3): 453–9. DOI: 10.1111/cen.13546</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Nayki U, Onk D, Balci G et al. The Effects of Diabetes Mellitus on Ovarian Injury and Reserve: An Experimental Study. Gynecol Obstet Invest 2016; 81 (5): 424–9. DOI: 10.1159/000442287</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Kadiroğulları P, Demir E, Bahat PY et al. Evaluation of relationship between HbA1c levels and ovarian reserve in patients with type 1 diabetes mellitus. Gynecol Endocrinol 2020; 36 (5): 426–30. DOI: 10.1080/09513590.2019.1708893</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Kim C, Karvonen-Gutierrez C, Kong S et al. Antimüllerian hormone among women with and without type 1 diabetes: the Epidemiology of Diabetes Interventions and Complications Study and the Michigan Bone Health and Metabolism Study. Fertil Steril 2016; 106 (6): 1446–52. DOI: 10.1016/j.fertnstert.2016.07.009</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Betterle C, Rossi A, Dalla Pria S et al. Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol (Oxf) 1993; 39 (1): 35–43. DOI: 10.1111/j.1365-2265.1993.tb01748.x</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Chen CW, Huang YL, Tzeng CR et al. Idiopathic Low Ovarian Reserve Is Associated with More Frequent Positive Thyroid Peroxidase Antibodies. Thyroid 2017; 27 (9): 1194–200. DOI: 10.1089/thy.2017.0139</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Polyzos NP, Sakkas E, Vaiarelli A et al. Thyroid autoimmunity, hypothyroidism and ovarian reserve: a cross-sectional study of 5000 women based on age-specific AMH values. Hum Reprod 2015; 30 (7): 1690–6. DOI: 10.1093/humrep/dev089</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Andrisani A, Sabbadin C, Marin L et al. The influence of thyroid autoimmunity on embryo quality in women undergoing assisted reproductive technology. Gynecol Endocrinol 2018; 34 (9): 752–5. DOI: 10.1080/09513590.2018.1442427</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Monteleone P, Parrini D, Faviana P et al. Female infertility related to thyroid autoimmunity: the ovarian follicle hypothesis. Am J Reprod Immunol 2011; 66 (2): 108–14. DOI i: 10.1111/j.1600-0897.2010.00961.x</mixed-citation></ref></ref-list></back></article>
